PRMT5 and hepatocellular carcinoma: IGF2BP1/IGF2BP3 stabilizes LINC01138 and, in HCC, LINC01138 binds specifically to protein arginine methyltransferase 5 (PRMT5), preventing its ubiquitination and degradation and enabling its oncogenic function.